PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9260987-2	1997	One possibility was that there was a more complete blockade of the renin system, which could also be achieved by an angiotensin II antagonist, eprosartan.	eprosartan	143-153	renin	Homo sapiens	67-72	
10904023-0	2000	Effect of angiotensin II antagonist eprosartan on hyperglycemia-induced activation of intrarenal renin-angiotensin system in healthy humans.	eprosartan	36-46	renin	Homo sapiens	97-102	
10904023-17	2000	The enhancement of the renal vasodilator effect of eprosartan during hyperglycemia is consistent with activation of the intrarenal renin-angiotensin system.	eprosartan	51-61	renin	Homo sapiens	131-136	
18855637-6	2008	An analysis has been made on available experimental and clinical data on eprosartan which not only is an effective and well tolerated antihypertensive agent, but also lowers the activities of the renin-angiotensin system and sympathetic nervous system.	eprosartan	73-83	renin	Homo sapiens	196-201	
10216807-20	1999	Both eprosartan and enalapril significantly increased plasma renin activity while plasma A-II was elevated in the eprosartan group.	eprosartan	5-15	renin	Homo sapiens	61-66	
9260987-11	1997	The renal vasodilator response to the angiotensin II antagonist eprosartan closely resembles responses to renin inhibition and exceeds previously reported responses to ACE inhibitors.	eprosartan	64-74	renin	Homo sapiens	106-111